Provider review
Wisp review
Semaglutide as drops under the tongue rather than an injection, and a candid sourcing note.
The bottle is sold by volume with no concentration, so the one calculation the format makes easy is the one you cannot do.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Wisp
$225/mo sublingual semaglutide drops, after a $99 consult
- Vs median
- $56/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The interesting thing here is the route. Almost everything on this page is a weekly subcutaneous injection, and for a reader deliberately holding a small dose that vehicle is the awkward part — a quarter dose means drawing a partial unit and trusting the markings on a syringe. Drops under the tongue sidestep that entirely, and Wisp is one of a handful of sellers offering them as a stocked product with a published price rather than something quoted on request. Two caveats travel with it, and Wisp states both itself rather than leaving them to be found. The first is that the product is described by volume and not by concentration, so there is no milligram anywhere: you cannot work out what a dose costs, how many doses a bottle holds, or whether taking less makes the bottle last longer, which is precisely the calculation the format would otherwise make easy. The second is in the footer, where the company discloses that the medications it offers are globally sourced and not FDA-approved and that the purchaser assumes that risk. That is a more candid disclosure than most of this category offers and it is also a material fact about provenance. The branded injectables are a different product entirely — prescriptions routed to a local pharmacy, with the pharmacy setting the price.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a needle-free route as a stocked product with a price, not quoted on request
- You would rather a seller state its sourcing plainly than leave you to work it out
- You have coverage and want branded prescriptions routed to your own pharmacy
Look elsewhere if
- You want to cost a specific dose. The bottle is sold by volume with no concentration
- You want one charge. A consult is billed before the medication figure applies
- You want a product tested in people rather than on tissue. The company says which this is
What it actually costs
Price as published
Compounded sublingual semaglutide drops, 15 mL, at $225/mo, sold beside a $99 weight-care consult and a $24 metformin prescription for PCOS · ★ the drops are a genuine non-injectable route, which matters for a small dose because a drop count is easier to control than a partial unit drawn into a syringe · the bottle is described by volume rather than concentration, so no milligram figure exists to attach the price to and there is no way to work out how long 15 mL lasts at a given dose · branded Wegovy, Zepbound and Saxenda are offered as prescriptions sent to a local pharmacy and are not priced here, so those are a pharmacy bill rather than a Wisp one · the site's own footer states the medications offered are "globally sourced" and non-FDA-approved and that the buyer assumes that risk · a separately sold capsule is marketed as a metabolic support and GLP-1 boost supplement and is not a GLP-1 · the company's own note says the sublingual base has been tested on human-derived tissue rather than in people
- Vs median
- $56/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. ★ A stocked sublingual product with a published price rather than injections only, which matters for a small dose because a drop count is easier to control than a partial unit in a syringe. The bottle is sold by VOLUME with no concentration published, so there is no way to work out what a dose costs or whether taking less makes the bottle last longer — the one calculation the format would otherwise make easy. A consult is charged separately before the medication figure applies. The site's own footer discloses that its medications are globally sourced and not FDA-approved. The branded injectables are routed to a local pharmacy and priced there, not here.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Billed separately
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- A stocked sublingual product with a published price, rather than injections only.
- Discloses the sourcing and the regulatory status of its medications in its own footer.
- Branded prescriptions can be routed to a local pharmacy for anyone with coverage.
Pharmacy, labs and oversight
Wisp does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is billed separately.
Transparency check
2 of 4 published openly
What Wisp publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The interesting thing here is the route. Almost every seller here sells a weekly subcutaneous injection, and for a reader deliberately holding a small dose that vehicle is the awkward part — a quarter dose means drawing a partial unit and trusting the markings on a syringe. Drops under the tongue sidestep that entirely, and Wisp is one of a handful of sellers offering them as a stocked product with a published price rather than something quoted on request. Two caveats travel with it, and Wisp states both itself rather than leaving them to be found. The first is that the product is described by volume and not by concentration, so there is no milligram anywhere: a reader cannot work out what a dose costs, how many doses a bottle holds, or whether taking less makes the bottle last longer, which is precisely the calculation the format would otherwise make easy. The second is in the footer, where the company discloses that the medications it offers are globally sourced and not FDA-approved and that the purchaser is assuming that risk. That is a more candid disclosure than most of this category offers and it is also a material fact about provenance. The branded injectables are a different product entirely — prescriptions routed to a local pharmacy, with the pharmacy setting the price.
The honest cons
The bottle is sold by volume with no concentration, so no dose can be costed.
- A consult is charged separately before the medication figure applies.
- The company states the sublingual base was tested on tissue rather than in people.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Wisp is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#237 of 373
Ordered with the companies that pay us first, and Wisp is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Sublingual troches and drops
- Is compounded GLP-1 safe?
- Microdose & reconstitution calculator
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.